Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2013; 19(31): 5138-5143
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5138
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5138
Figure 1 Inhibition of herpes simplex virus encoding granulocyte-macrophage colony-stimulating factor on the proliferation of PANC-2 pancreatic carcinoma xenografts in mice.
A: Control group; B: High dosage; C: Middle dosage; D: Low dosage. Fifteen days later, after decapitation of the animals by cervical dislocation, each tumor was isolated.
- Citation: Liu H, Yuan SJ, Chen YT, Xie YB, Cui L, Yang WZ, Yang DX, Tian YT. Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma. World J Gastroenterol 2013; 19(31): 5138-5143
- URL: https://www.wjgnet.com/1007-9327/full/v19/i31/5138.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i31.5138